Professor Bill Denny


Bill Denny is a graduate of Auckland University, and trained at Auckland and Oxford Universities as a medicinal chemist.

He is currently Director of the Auckland Cancer Society Research Centre in the University of Auckland’s School of Medical Sciences, where he has been closely involved in the development of eight drugs from the Centre into clinical trials, in collaboration with different industrial partners.

He is a principal investigator in the Maurice Wilkins Centre (one of the national Centres of Research Excellence), and is co-chair of the University’s Biopharma Research Initiative.

He is a scientific co-founder of the biotech companies Proacta Inc and Pathway Therapeutics, and a scientific advisory board member of the Australian Research Centre for Cancer Therapeutics. He is also a co-author of 600 scientific papers and 100 patent applications in the area of drug design and development, a Rutherford Medallist of the Royal Society of NZ, and an Officer of the NZ Order of Merit.